Experimental group:Kangfuxin Solution

2 trials

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University, Sichuan Cancer Hospital

Conditions

Radiation-induced skin injurynasopharyngeal carcinoma

Early Phase 1

KANGFUXIN solution for the prevention of radiation-induced skin injury in breast cancer patients: A pilot study.

Active, not recruitingChiCTR2300075483

The First Affiliated Hospital of Guangdong Pharmaceutical UniversityRadiation-induced skin injury

Start: 2022-10-08Updated: 2023-09-11

Phase 4

A multicenter, randomized, controlled trial: the effect of Kangfuxin Solution on the radiation induced oral and upper gastrointestinal mucositis in nasopharyngeal carcinoma patients

Active, not recruitingChiCTR-IPR-15006687

Sichuan Cancer Hospitalnasopharyngeal carcinoma

Start: 2012-07-24Updated: 2017-04-18